Current Updates on Cardiovascular Diseases in Emergency Medicine

A special issue of Journal of Personalized Medicine (ISSN 2075-4426). This special issue belongs to the section "Clinical Medicine, Cell, and Organism Physiology".

Deadline for manuscript submissions: 25 October 2024 | Viewed by 2351

Special Issue Editor


E-Mail Website
Guest Editor
1. 2nd Department of Anaesthesiology and Intensive Care, “Prof Dr CC Iliescu” Emergency Institute for Cardiovascu-lar Diseases, 022322 Bucharest, Romania
2. Department of Anaesthesiology, ‘Carol Davila’ University of Medicine and Pharmacy, 050474 Bucharest, Romania
Interests: anesthesiology; intensive care; cardiovascular disease

Special Issue Information

Dear Colleagues,

Cardiovascular diseases (CVDs) are a leading cause of morbidity and mortality worldwide. The ever-urgent need for rapid, decisive action in emergency medical settings is a testament to the evolving understanding and management of these conditions.

Historically, the intersection of emergency medicine and cardiology has been pivotal in the development of lifesaving protocols. From the advent of defibrillation to the application of thrombolytics, the progress has been monumental.

This Special Issue aims to encapsulate and highlight the most recent advancements in the diagnosis, treatment, and management of cardiovascular emergencies. We seek to illuminate the path forward by showcasing the depth and breadth of current research, translating complex clinical challenges into actionable knowledge.

We encourage the submission of original research articles, reviews, and other manuscripts that discuss state-of-the-art interventions, emerging diagnostic tools, and novel therapeutic approaches. Manuscripts that evaluate the efficacy of new protocols and those that explore the integration of technology in emergency care settings are especially welcome.

We are soliciting contributions that push the boundaries of knowledge and practice. Research that underscores interdisciplinary approaches is sought for this Special Issue.

We invite authors to contribute their expertise and insights to this critical discourse, engaging with a community dedicated to the advancement of emergency cardiovascular care. By participating, you will be contributing to a compendium that not only informs but also shapes the future of emergency medicine.

Dr. Mihai Ștefan
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • cardiovascular diseases
  • emergency medicine
  • rapid intervention
  • diagnostic modalities
  • treatment strategies
  • point-of-care testing
  • pharmacological interventions
  • procedural techniques
  • clinical trials
  • innovative technologies
  • patient monitoring
  • evidence-based practices
  • interdisciplinary approach
  • policy implications
  • advanced cardiac care
  • thrombolytics
  • defibrillation
  • acute cardiac events
  • research and development in cardiology

Published Papers (3 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Review

14 pages, 1015 KiB  
Review
The Management of Aortic Coarctation Associated with Hypoplastic Arches and Particular Arch Anatomies: A Literature Review
by Irina-Maria Margarint, Tammam Youssef, Mircea Robu, Iulian Rotaru, Alexandru Popescu, Olguta Untaru, Cristina Filip, Ovidiu Stiru, Vlad Anton Iliescu and Radu Vladareanu
J. Pers. Med. 2024, 14(7), 732; https://doi.org/10.3390/jpm14070732 - 6 Jul 2024
Viewed by 395
Abstract
The surgical management of aortic coarctation in newborns needs to ensure postoperative evolution and long-term results as much as possible. Patients with a Gothic arch have a higher rate of postoperative hypertension, while newborns with a bovine arch have higher rates of restenosis [...] Read more.
The surgical management of aortic coarctation in newborns needs to ensure postoperative evolution and long-term results as much as possible. Patients with a Gothic arch have a higher rate of postoperative hypertension, while newborns with a bovine arch have higher rates of restenosis and, thus, an additional risk of mortality. Late hypertension, even in anatomically successfully repaired patients, confers a high risk for cardiovascular events. This review of the literature focuses on the management of aortic coarctations associated with hypoplastic arch and particular arch anatomies, focusing on surgical techniques and their outcomes. Full article
(This article belongs to the Special Issue Current Updates on Cardiovascular Diseases in Emergency Medicine)
Show Figures

Figure 1

12 pages, 5123 KiB  
Review
Combined Endovascular and Endoscopic Management of a Secondary Aortoesophageal Fistula after Open Surgical Aortic Repair in a Giant Descending Thoracic Aortic Pseudoaneurysm: Case Report and Review of Literature
by Ovidiu Stiru, Reza Nayyerani, Mircea Robu, Roxana Carmen Geana, Petru Razvan Dragulescu, Oana Andreea Blibie, Serban-Ion Bubenek-Turconi, Vlad Anton Iliescu and Catalina Parasca
J. Pers. Med. 2024, 14(6), 625; https://doi.org/10.3390/jpm14060625 - 11 Jun 2024
Viewed by 750
Abstract
Secondary aortoesophageal fistula (AEF) is defined as a communication between the aorta and the esophagus, occurring after aortic disease treatment or esophageal procedures, associating very high mortality rates with treatment and being fatal without it. Several treatment strategies have been described in the [...] Read more.
Secondary aortoesophageal fistula (AEF) is defined as a communication between the aorta and the esophagus, occurring after aortic disease treatment or esophageal procedures, associating very high mortality rates with treatment and being fatal without it. Several treatment strategies have been described in the literature, combining open surgery or endovascular aortic repair with surgical or endoscopic management of the esophageal lesion. We present the case of a 53-year-old patient with a history of open aortic surgery for a giant descending thoracic aortic pseudoaneurysm complicated with secondary AEF, successfully managed using emergency transiliac TEVAR (thoracic endovascular aortic repair), extensive antibiotic therapy associated with nutritional replenishment, and rehabilitation therapy. Novel endovascular and endoscopic devices have been developed, offering less invasive treatment strategies with improved outcomes, especially for high risk surgical patients. This case highlights the importance of a multidisciplinary approach to personalized medicine to manage such complex situations. Full article
(This article belongs to the Special Issue Current Updates on Cardiovascular Diseases in Emergency Medicine)
Show Figures

Figure 1

10 pages, 5017 KiB  
Review
Hybrid Management of Dysphagia Lusoria with Tevar Implantation and Bilateral Subclavian Arteries Debranching: A Review of the Literature and a Case Report
by Ovidiu Stiru, Mircea Robu, Pavel Platon, Serban-Ion Bubenek-Turconi, Vlad Anton Iliescu and Catalina Parasca
J. Pers. Med. 2024, 14(6), 547; https://doi.org/10.3390/jpm14060547 - 21 May 2024
Cited by 1 | Viewed by 688
Abstract
Aberrant right subclavian artery (ARSA) causing dysphagia, the so-called “dysphagia lusoria”, is a frequent embryologic anomaly of the aortic arch. In symptomatic patients, studies report several management options including surgical, hybrid, and totally endovascular strategies. Hybrid techniques have the advantage of no chest [...] Read more.
Aberrant right subclavian artery (ARSA) causing dysphagia, the so-called “dysphagia lusoria”, is a frequent embryologic anomaly of the aortic arch. In symptomatic patients, studies report several management options including surgical, hybrid, and totally endovascular strategies. Hybrid techniques have the advantage of no chest opening with reduced morbidity, but the problem of the ARSA stump causing recurrent or persistent dysphagia remains challenging in some cases. We conducted a literature review on the management strategies of ARSA and presented the case of a 72-year-old female patient with ARSA and dysphagia managed with thoracic endovascular repair of the aorta (TEVAR) and bilateral carotid–subclavian artery bypass. This technique was chosen because of the severe calcifications at the level of ARSA origin that would make surgical ligation difficult, or if an occluder device not suitable. We think that a patient-tailored approach should be considered in cases of dysphagia lusoria, considering that a multitude of strategies are reported. Full article
(This article belongs to the Special Issue Current Updates on Cardiovascular Diseases in Emergency Medicine)
Show Figures

Figure 1

Back to TopTop